Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors-Reference-Cited by-同舟云学术

Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors

Published:2008-08 Issue:2 Volume:48 Page:508-518
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yu Jun,Tao Qian,Cheung Kin F.,Jin Hongchuan,Poon Fan Fong,Wang Xian,Li Hongyu,Cheng Yuen Y.,Röcken Christoph,Ebert Matthias P. A.,Chan Anthony T. C.,Sung Joseph J. Y.

Publisher

Wiley

Subject

Hepatology

Reference35 articles.

1. The fundamental role of epigenetic events in cancer;Jones;Nat Rev Genet,2002

2. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future;Esteller;Oncogene,2002

3. DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas?;Grady;Gut,2007

4. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction?;Baylin;Nat Rev Cancer,2006

5. Detection and interpretation of altered methylation patterns in cancer cells;Ushijima;Nat Rev Cancer,2005

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary biomarkers associated with podocyte injury in lupus nephritis;Frontiers in Pharmacology;2024-01-19

2. In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin–like growth factor 2 mRNA–binding protein 1 in hepatocellular carcinoma;Hepatology Communications;2023-09-15

3. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma;Pathology - Research and Practice;2023-07

4. A review of deubiquitinases and thier roles in tumorigenesis and development;Frontiers in Bioengineering and Biotechnology;2023-05-12

5. Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review);Oncology Letters;2023-02-08